Stroke, AcuteNCT04171856
Exploring Motor Learning in Acute Stroke Through Robotics
A study testing REAplan(R) in people with Stroke, Acute, run by University Hospital of Mont-Godinne at 2 sites in Belgium.
Trial summary
The acute phase of stroke is characterized by an enhancement of neural plasticity which supports rapid motor recovery. It is unclear whether acute stroke patients can acquire new motor skills with their affected upper limb. The aims of this research program are: 1. Read more about this study
- Who is it for?
- Ages 18 to 90 yearsHealthy volunteers can take part
- Conditions the study is for
- Stroke, Acute
- What is being tested?
- REAplan(R)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 245 participants
- Where
- 2 sitesBelgium
- Study dates
- 1 Jan 2020to 1 Jul 2040
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- acute stroke (> 21 days)
- aged 18-90 years
- with a stroke lesion on brain imaging
- Transient global amnesia
- 8-90 years old
- Be able to perform 3 consecutive sessions on a rehabilitation robot
Show all 10Show fewer
- 18-90 years
- chronic stroke (>6 months)
- aged 18-90 years
- with a stroke lesion on brain imaging
Who cannot join
- " classical " contre-indication to MRI (non-MR-compatible pacemaker, pregnancy, non-MR-compatible implanted devices, claustrophoby, etc ...)
- difficulty in understanding or executing commands
- drug/alcohol abuse
- severe aphasia / cognitive deficits interfering with study
- inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
- multiple strokes / dementia / psychiatric condition
Show all 28Show fewer
- PATIENTS WITH TRANSIENT GLOBAL AMNESIA:
- Clinical diagnosis, criteria of Hodge \& Warlow (1990):
- Anterograde amnesia observed by a witness
- No alteration of consciousness or loss of identity
- Cognitive dysfunction limited to amnesia
- Lack of focused neurological deficit or argument for a comitiality
- Absence of head trauma
- Symptom resolution within 24 hours
- Possible existence of vegetative symptoms
- Severe aphasia / cognitive deficits interfering with study
- Psychiatric disorders
- Alcohol / drug addiction
- HEALTHY INDIVIDUALS:
- medical history with a previous stroke/neurological deficit
- drug/alcohol abuse
- psychiatric condition/ dementia
- CHRONIC STROKE PATIENTS:
- difficulty in understanding or executing commands
- drug/alcohol abuse
- severe aphasia / cognitive deficits interfering with study
- inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
- multiple strokes / dementia / psychiatric condition
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Belgium2 sites, 2 recruiting
- Recruiting
CHU UCL Namur
Yvoir, Namur, 5530
Eloïse Gerardin, +3281423348, eloise.gerardin@uclouvain.be
- Not yet recruiting
University Hospital CHU Dinant Godinne UCL
Yvoir, 5530
Yves Vandermeeren, MD, PhD, yves.vandermeeren@uclouvain.be
About this study
The acute phase of stroke is characterized by an enhancement of neural plasticity which supports rapid motor recovery. It is unclear whether acute stroke patients can acquire new motor skills with their affected upper limb. The aims of this research program are:
- To test the capacity of acute stroke patients (< 21 days) to learn and retain a complex unimanual motor skill.
- To explore whether acute stroke to different brain regions (quantified with brain MRI) induces specific deficits in motor skill learning.
- To compare acute stroke patients with healthy individuals and with chronic stroke patients.
Read the detailed description
Over 3 consecutive days, the subjects will be evaluated and will train on the rehabilitation robot REAplan® (http://www.axinesis.com/). They will practice 2 serious games on the robot.
In order to differentiate the effect of motor control recovery from that of MskL, the acute stroke patients will be randomised 4/1 to "MskL" (n=120) ,to "motor control recovery" (n=30) or to "conventional" group (n=15) with a minimisation software. The experimental design will be similar except that the "motor control recovery" group will practice the serious game EASY instead of CIRCUIT (see below) and the "conventional" group will practice conventional therapy instead of CIRCUIT. The performances on both EASY \& CIRCUIT will be compared between groups (subjects in both groups will perform the EASY \& CIRCUIT tasks).The total time of rehabilitation will be the same.
The motor skill learning setup (CIRCUIT + EASY) that we developed and successfully used in healthy individuals and stroke patients has already been implemented in the REAplan environment and will be used as innovative serious games based on a speed/accuracy trade-off (SAT), allowing a detailed analysis of motor skill learning components (speed, accuracy, SAT, movement smoothness, dynamics...). For the serious game CIRCUIT, who based on motor skill learning, the subjects will have to practice a complex circuit and move as a cursor quickly and accurately as possible by controlling the handle of the robot with their affected hand/arm. For the other task EASY (a brick busters serious game), the aim will be to go back and forth between walls presented in different locations. The CONVENTIONAL therapy will consist in classical exercices focused in the upper limb administered by occupational therapist.
The subacute stroke phase is a unique opportunity to investigate the role of brain structures in motor learning/control. Compared to chronic impairments (> 6 months post-stroke), the subacute phase provides a window into how a lesion perturbs sensorimotor functions prior to reorganisation driven by plasticity and neurorehabilitation. To clarify the role of different brain structures in MskL, Voxel-based Lesion Symptom Mapping (VLSM) based on high-resolution brain magnetic resonance imaging (MRI) scans, will be used to analyse the relationship between tissue damage and MskL scores on a voxel-by-voxel basis.
In addition, several "classical" clinical scales and tests will be used to evaluate overall motor-sensory-cognitive functions. The subjects will practice serious games on the robot REAplan (R), requiring movements with the affected arm (unimanual tasks).
And, we used a Dextrain® tool which allows quantification of key components of manual dexterity : forces, selectivity (independance of fingers movement) and coactivation of the fingers.Moreover, we added a Transcranial magnetic stimulation (TMS), as a tool for predicting recovery of motor function after stroke.
In addition to the (sub)acute stroke patients, 4 others groups will be recruited for this study : a group of acute stroke patients who will receive "conventional rehabilitation" and be shortly tested on the robot (N=15), a group of chronic stroke patients (stroke > 6 months) who will not be hospitalized and will not undergo MRI (N=30), a group of healthy individuals who will not undergo MRI (N=50) and a group of patients with a transient global amnesia which is a sudden, temporary episode (<24hours) of memory loss (N=15).
Subjects in these 4 groups will be randomized 1/1 in the two arms ("MSkL" versus "motor control recovery" arms), except the patients with a TGA who will be included in the "MSkL" arm only.
- Conditions
- Stroke, Acute
- Being tested
- REAplan(R)
- Keywords
- Acute stroke, Motor skill learning, Upper limb, Rehabilitation, Subacute stroke
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
REAplan(R)Device
motor skill learning with the REAplan(R) rehabilitation robot, to be perfomed with the affected arm
| Study group | Role | What they receive |
|---|---|---|
| Motor Skill Learning (CIRCUIT) | Experimental | Intervention: training on the REAplan robot with a serious game based on motor skill learning (MSkL) serious game, the CIRCUIT. Receives: Device: REAplan(R) |
| Motor control recovery (EASY) | Active comparator | Training on the REAplan robot with a serious game that requires similar type and amount of movements but does not rely on motor skill learning (EASY), a brick buster game. Receives: Device: REAplan(R) |
| Conventional | Active comparator | Training sessions with classical exercices focused on the upper limb administered by occupation therapist. Receives: Device: REAplan(R) |
What is being measured
The primary outcome is the main question the study is designed to answer.
change in SAT (CIRCUIT)
Speed/ Accuracy Trade-off
Measured: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
total distance travelled (EASY)
total distance travelled between the walls of the brick busters (in cm)
Measured: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Secondary outcomes (11)
Fugl Meyer Upper Extremity Test
Tests impairments of the upper limb after stroke
Measured: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Arm Motor Ability (AMA) test
Measure disabilities of the upper limb after stroke
Measured: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Fatigue Visual Analog Scale (VAS)
Visual Analog Scale to evaluate fatigue between 0 and 10. The maximum value (10) indicate a high level of fatiguability.
Measured: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Voxel-based Lesion Symptom Mapping (VLSM)
High-resolution 3D-MRI, diffusion MRI (DWI) \& perfusion MRI (PWI with Arterial SPin Labelling technique) will be acquired. The stroke areas will be drawn with MRIcron as volumes of interest (VOI) in native space and compared.
Measured: Baseline
Dextrain®
Quantitative assessment of the manual dexterity : fingers strength and selectivity, coactivation.
Measured: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Grober and Buschke test (16 items) (for patients with trasient global amnesia)
Assessement of episodic verbal memory
Measured: Baseline
Brief Visuospatial Memory Test-Revised
Measure of visuospatial memory (for patients with trasient global amnesia)
Measured: Baseline
Forces of the upper limb on the REAplan robot (CIRCUIT, EASY, REACHING)
To evaluate the Force of the upper limb after stroke (Newton)
Measured: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Spectral Arc Lenght on the REAplan robot (CIRCUIT, EASY, REACHING)
Movement smoothness quantification
Measured: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Total distance of the upper limb on the REAplan robot (CIRCUIT, EASY, REACHING)
Measure of total distance traveled during the training (cm)
Measured: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
transcranial magnetic stimulation (TMS)
Measure of the prediction recovery after stroke
Measured: correlation with the measure realized Day 1 with progression of the motor skill learning (change between Baseline Day1 and Day 3)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Nov 2019
- Study start1 Jan 2020
- Primary completion1 May 2030 (estimated)
- Study completion1 Jul 2040 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stroke, AcuteStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 245 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital of Mont-Godinne
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Pr Yves Vandermeeren, MD, PhD, University Hospital of Mont-Godinne
- Investigators
- Yves Vandermeeren, MD, PhD, Principal investigator, UCLouvain IONS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04171856
- Sponsor's protocol ID
- B039201938990
- Status last verified
- Aug 2026
- First submitted
- 12 Nov 2019
- Last updated
- 12 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: the precise IPD plan has to be worked out if an easy and user-friendly solution is available, we intend to make the data available (after anonymisation of personal data).
Study at a glance
From the registry record, last updated by the sponsor on 12 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exploring Motor Learning in Acute Stroke Through Robotics
- ClinicalTrials.gov ID
- NCT04171856
- Acronym / sponsor ID
- B039201938990
- Conditions
- Stroke, Acute
- Keywords
- Acute stroke, Motor skill learning, Upper limb, Rehabilitation, Subacute stroke
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 245 participants (estimated)
- Lead sponsor
- University Hospital of Mont-GodinneUniversity, hospital or other
- Study start
- 1 Jan 2020 (actual)
- Primary completion
- 1 May 2030 (estimated)
- Study completion
- 1 Jul 2040 (estimated)
- First posted
- 21 Nov 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The acute phase of stroke is characterized by an enhancement of neural plasticity which supports rapid motor recovery. It is unclear whether acute stroke patients can acquire new motor skills with their affected upper limb. The aims of this research program are:
- To test the capacity of acute stroke patients (< 21 days) to learn and retain a complex unimanual motor skill.
- To explore whether acute stroke to different brain regions (quantified with brain MRI) induces specific deficits in motor skill learning.
- To compare acute stroke patients with healthy individuals and with chronic stroke patients.
Detailed description
Over 3 consecutive days, the subjects will be evaluated and will train on the rehabilitation robot REAplan® (http://www.axinesis.com/). They will practice 2 serious games on the robot.
In order to differentiate the effect of motor control recovery from that of MskL, the acute stroke patients will be randomised 4/1 to "MskL" (n=120) ,to "motor control recovery" (n=30) or to "conventional" group (n=15) with a minimisation software. The experimental design will be similar except that the "motor control recovery" group will practice the serious game EASY instead of CIRCUIT (see below) and the "conventional" group will practice conventional therapy instead of CIRCUIT. The performances on both EASY \& CIRCUIT will be compared between groups (subjects in both groups will perform the EASY \& CIRCUIT tasks).The total time of rehabilitation will be the same.
The motor skill learning setup (CIRCUIT + EASY) that we developed and successfully used in healthy individuals and stroke patients has already been implemented in the REAplan environment and will be used as innovative serious games based on a speed/accuracy trade-off (SAT), allowing a detailed analysis of motor skill learning components (speed, accuracy, SAT, movement smoothness, dynamics...). For the serious game CIRCUIT, who based on motor skill learning, the subjects will have to practice a complex circuit and move as a cursor quickly and accurately as possible by controlling the handle of the robot with their affected hand/arm. For the other task EASY (a brick busters serious game), the aim will be to go back and forth between walls presented in different locations. The CONVENTIONAL therapy will consist in classical exercices focused in the upper limb administered by occupational therapist.
The subacute stroke phase is a unique opportunity to investigate the role of brain structures in motor learning/control. Compared to chronic impairments (> 6 months post-stroke), the subacute phase provides a window into how a lesion perturbs sensorimotor functions prior to reorganisation driven by plasticity and neurorehabilitation. To clarify the role of different brain structures in MskL, Voxel-based Lesion Symptom Mapping (VLSM) based on high-resolution brain magnetic resonance imaging (MRI) scans, will be used to analyse the relationship between tissue damage and MskL scores on a voxel-by-voxel basis.
In addition, several "classical" clinical scales and tests will be used to evaluate overall motor-sensory-cognitive functions. The subjects will practice serious games on the robot REAplan (R), requiring movements with the affected arm (unimanual tasks).
And, we used a Dextrain® tool which allows quantification of key components of manual dexterity : forces, selectivity (independance of fingers movement) and coactivation of the fingers.Moreover, we added a Transcranial magnetic stimulation (TMS), as a tool for predicting recovery of motor function after stroke.
In addition to the (sub)acute stroke patients, 4 others groups will be recruited for this study : a group of acute stroke patients who will receive "conventional rehabilitation" and be shortly tested on the robot (N=15), a group of chronic stroke patients (stroke > 6 months) who will not be hospitalized and will not undergo MRI (N=30), a group of healthy individuals who will not undergo MRI (N=50) and a group of patients with a transient global amnesia which is a sudden, temporary episode (<24hours) of memory loss (N=15).
Subjects in these 4 groups will be randomized 1/1 in the two arms ("MSkL" versus "motor control recovery" arms), except the patients with a TGA who will be included in the "MSkL" arm only.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Motor Skill Learning (CIRCUIT) | Experimental | Device: REAplan(R)Intervention: training on the REAplan robot with a serious game based on motor skill learning (MSkL) serious game, the CIRCUIT. |
| Motor control recovery (EASY) | Active comparator | Device: REAplan(R)Training on the REAplan robot with a serious game that requires similar type and amount of movements but does not rely on motor skill learning (EASY), a brick buster game. |
| Conventional | Active comparator | Device: REAplan(R)Training sessions with classical exercices focused on the upper limb administered by occupation therapist. |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (10 listed)
- acute stroke (> 21 days)
- aged 18-90 years
- with a stroke lesion on brain imaging
- Transient global amnesia
- 8-90 years old
Key exclusion criteria (28 listed)
- " classical " contre-indication to MRI (non-MR-compatible pacemaker, pregnancy, non-MR-compatible implanted devices, claustrophoby, etc ...)
- difficulty in understanding or executing commands
- drug/alcohol abuse
- severe aphasia / cognitive deficits interfering with study
- inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| REAplan(R)motor skill learning with the REAplan(R) rehabilitation robot, to be perfomed with the affected arm | Device | Conventional, Motor Skill Learning (CIRCUIT), Motor control recovery (EASY) |
Primary outcome
change in SAT (CIRCUIT)
Time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Speed/ Accuracy Trade-off
total distance travelled (EASY)
Time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
total distance travelled between the walls of the brick busters (in cm)
11 secondary outcomes
Fugl Meyer Upper Extremity Test
Time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Arm Motor Ability (AMA) test
Time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Fatigue Visual Analog Scale (VAS)
Time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Voxel-based Lesion Symptom Mapping (VLSM)
Time frame: Baseline
Dextrain®
Time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Grober and Buschke test (16 items) (for patients with trasient global amnesia)
Time frame: Baseline
Brief Visuospatial Memory Test-Revised
Time frame: Baseline
Forces of the upper limb on the REAplan robot (CIRCUIT, EASY, REACHING)
Time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Spectral Arc Lenght on the REAplan robot (CIRCUIT, EASY, REACHING)
Time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
Total distance of the upper limb on the REAplan robot (CIRCUIT, EASY, REACHING)
Time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)
transcranial magnetic stimulation (TMS)
Time frame: correlation with the measure realized Day 1 with progression of the motor skill learning (change between Baseline Day1 and Day 3)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Aug 2026.
- Individual participant dataSharing planned: Yes. the precise IPD plan has to be worked out if an easy and user-friendly solution is available, we intend to make the data available (after anonymisation of personal data).
Related trials for Stroke, Acute
Recruiting
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
Stroke, Acute
RecruitingObservational study
Implementing Transcranial Direct Current Stimulation in a Rehabilitation Setting
Aphasia, Stroke
RecruitingObservational study
Natural History of Stroke: Cause and Development
Brain Disease, Ischemic Attack, Transient
Not yet recruiting
Prehospital Response and Emergency Stroke Transport Optimisation
Acute Ischemic Stroke
Active, not recruitingObservational study
Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project
Stroke, Acute, Gait, Hemiplegic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Yves Vandermeeren, MD, PhD principal investigator
UCLouvain IONS
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing REAplan(R) in people with Stroke, Acute, run by University Hospital of Mont-Godinne at 2 sites in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 28 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Yves Vandermeeren, MD, PhD (+32 81 42 33 21, yves.vandermeeren@uclouvain.be), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
change in SAT (CIRCUIT) (time frame: change between Baseline Day1 and Day3 (acute) + between Baseline Day1 and 3/6 and 12 months post-stroke (subacute - chronic)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026.